Renaissance Technologies’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,200
Closed -$53K 4547
2022
Q3
$53K Sell
7,200
-5,637
-44% -$68.5K ﹤0.01% 3746
2022
Q2
$159K Buy
12,837
+8,211
+177% +$77K ﹤0.01% 3734
2022
Q1
$77K Buy
4,626
+75
+2% +$2.41K ﹤0.01% 3838
2021
Q4
$296K Sell
4,551
-109
-2% -$6.35K ﹤0.01% 3349
2021
Q3
$319K Sell
4,660
-100
-2% -$7.15K ﹤0.01% 3062
2021
Q2
$332K Sell
4,760
-6,805
-59% -$368K ﹤0.01% 3111
2021
Q1
$759K Buy
11,565
+3,597
+45% +$273K ﹤0.01% 2734
2020
Q4
$458K Sell
7,968
-1,048
-12% -$61K ﹤0.01% 2859
2020
Q3
$536K Buy
9,016
+5,334
+145% +$476K ﹤0.01% 2792
2020
Q2
$477K Buy
+3,682
New +$325K ﹤0.01% 2898
2019
Q4
Sell
-242
Closed -$29K 3817
2019
Q3
$29K Buy
+242
New +$48.7K ﹤0.01% 3358
2017
Q2
Sell
-61
Closed -$75K 3421
2017
Q1
$75K Sell
61
-262
-81% -$126K ﹤0.01% 3111
2016
Q4
$130K Buy
323
+79
+32% +$31.5K ﹤0.01% 3063
2016
Q3
$100K Buy
244
+88
+56% +$39.3K ﹤0.01% 3180
2016
Q2
$76K Buy
+156
New +$79.2K ﹤0.01% 3198

Other funds holding HTGM